Position
Chief Commercial Officer
Company
Iovance Biotherapeutics
San CarlosManufacturingBiotechnologyHealth CareTherapeuticsDescription
Iovance Biotherapeutics has announced the appointment of Dan Kirby as the Chief Commercial Officer. Mr. Kirby will join the executive leadership team in the newly created role to oversee the U.S
Quick answer
Iovance Biotherapeutics Appoints Dan Kirby as Chief Commercial Officer (February 16, 2025). Iovance Biotherapeutics is based in San Carlos, California, United States.
- Who is the new Chief Commercial Officer at Iovance Biotherapeutics?
- Iovance Biotherapeutics named Dan Kirby Chief Commercial Officer, announced February 16, 2025.
- What did Iovance Biotherapeutics announce on February 16, 2025?
- Iovance Biotherapeutics has announced the appointment of Dan Kirby as the Chief Commercial Officer.
- What does Iovance Biotherapeutics do?
- Iovance Biotherapeutics (NASDAQ: IOVA) aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapies for patients with cancer.
- Where is Iovance Biotherapeutics based?
- Iovance Biotherapeutics is based in San Carlos, California, United States.
- Which similar companies made leadership changes around the same time?
- Bristol Myers Squibb (February 21, 2025), Cerenome, Inc. (February 24, 2025), Planatome (February 19, 2025) and Revelation Pharma (February 12, 2025) also announced leadership changes within 45 days of Iovance Biotherapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Manufacturing
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Bristol-Myers Squibb Appoints Cari Gallman as Executive Vice President and General Counsel, Succeeding Sandra Leung (February 21, 2025)
- Plus Therapeutics Appoints Michael Rosol, Ph.D., as Chief Development Officer (February 24, 2025)
- Planatome Appoints Craig Bushnell as Business Development and Chief Commercial Officer (February 19, 2025)
- Revelation Pharma Promotes Nancy Fingerhut to Vice President of Quality Assurance and Regulatory Affairs (February 12, 2025)
- Breg, Inc. Names Steve Ingel as President (February 11, 2025)
- Aadi Bioscience Appoints David Dornan, PhD as Chief Scientific Officer (CSO) (February 20, 2025)
Who to call at Iovance Biotherapeutics, and when
A new leader at Iovance Biotherapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Iovance Biotherapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Iovance Biotherapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Iovance Biotherapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Iovance Biotherapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Iovance Biotherapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.